\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ and\\ laboratory\\:\\ \ \(0\)\
\-\ no\\ pertinent\\ findings\ \(0\)\
\-\ treatment\\ and\\ follow\\-up\\:\\ \ \(0\)\
\-\ diuresis\\ for\\ pleural\\ effusions\\ initially\\ which\\ decreased\\ the\\ patient\\â\\€\\™s\\ symptom\\ of\\ dyspnea\\ on\\ exertion\ \(0\)\
\-\ placement\\ of\\ ureteral\\ stents\\ due\\ to\\ compression\\ of\\ left\\ ureter\\ causing\\ hydronephrosis\ \(0\)\
\-\ chemotherapy\\ started\\ at\\ diagnosis\\ and\\ continued\\ for\\ greater\\ than\\ one\\ year\ \(0\)\
\-\ patient\\ succumbed\\ to\\ her\\ disease\\ approximately\\ 15\\ months\\ following\\ her\\ diagnosis\ \(0\)\
\-\ image\\ findings\\:\\ \ \(0\)\
\-\ cxr\\ \\(ap\\ portable\\)\\:\\ mediastinal\\ mass\\,\\ left\\ pleural\\ effusion\ \(0\)\
\-\ chest\\ ct\\:\\ large\\ mediastinal\\ mass\\ spanning\\ the\\ anterior\\,\\ middle\\,\\ and\\ posterior\\ mediastinum\\ and\\ descending\\ into\\ abdomen\\ and\\ \\ \\ \\ \\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ encircling\\ the\\ aorta\\,\\ large\\ left\\ and\\ right\\ pleural\\ effusions\ \(1\)\
\-\ abdomen\\ and\\ pelvis\\ ct\\:\\ large\\ mass\\ descending\\ from\\ mediastinum\\ into\\ the\\ retroperitoneal\\ space\\ and\\ into\\ the\\ pelvis\\ compressing\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ the\\ inferior\\ vena\\ cava\\,\\ hydronephrosis\\ of\\ the\\ left\\ kidney\ \(0\)\
\-\ diffuse\\ rhabdomyosarcoma\ \(0\)\
\-\ differential\\ diagnosis\\ for\\ these\\ findings\\ in\\ this\\ case\\:\ \(0\)\
\-\ based\\ on\\ cxr\\:\\ malignancy\\,\\ granulomatous\\ disease\\,\\ other\\ inflammation\\ \\(abscess\\/pneumonia\\)\\,\\ benign\\ neoplasm\\,\\ and\\ congenital\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ anomaly\ \(1\)\
\-\ based\\ on\\ ct\\:\\ lymphoma\\,\\ other\\ malignancy\\ \\(most\\ likely\\ soft\\ tissue\\ in\\ origin\\)\\,\\ metastatic\\ disease\ \(0\)\
\-\ history\\ \\(can\\ include\\ gestational\\ age\\,\\ or\\ age\\ in\\ days\\,\\ weeks\\,\\ months\\)\\:\ \(0\)\
\-\ previously\\ healthy\\ 13\\ y\\/o\\ female\\ with\\ shortness\\ of\\ breath\\ on\\ exertion\\.\ \(0\)\
\-\ discussion\\ \\(include\\ references\\)\\:\\ \ \(0\)\
\-\ rhabdomyosarcoma\\ is\\ the\\ most\\ common\\ soft\\ tissue\\ sarcoma\\ of\\ childhood\\ and\\ adolescence\\,\\ usually\\ arising\\ before\\ age\\ 20\\.\\ \\ it\\ is\\ classified\\ into\\ three\\ histological\\ subtypes\\:\\ embryonal\\,\\ the\\ most\\ common\\ subtype\\ often\\ with\\ the\\ best\\ prognosis\\;\\ alveolar\\,\\ the\\ most\\ common\\ subtype\\ in\\ adolescents\\ and\\ this\\ patient\\â\\€\\™s\\ final\\ diagnosis\\;\\ and\\ pleomorphic\\,\\ the\\ least\\ common\\ of\\ the\\ three\\ subtypes\\.\\ \\ overall\\,\\ in\\ children\\,\\ 65\\%\\ of\\ patients\\ diagnosed\\ with\\ rhabdomyosarcoma\\ are\\ cured\\ with\\ treatment\\ consisting\\ of\\ chemotherapy\\,\\ surgery\\,\\ and\\ occasionally\\ radiation\\.\\ \\ \ \(0\)\
\-\ information\\ from\\ robbins\\ pathologic\\ basis\\ of\\ disease\\.\\ 6th\\ ed\\.\\ 1999\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.04424710342393277\ \(0\)\
\-\ \\:\\:\\ 0\\.04160520795057663\ \(0\)\
\-\ subtypes\\:\\ 0\\.03540488335118451\ \(0\)\
\-\ subtype\\:\\ 0\\.03540488335118451\ \(0\)\
\-\ exertion\\:\\ 0\\.030729177510406006\ \(0\)\
\-\ pleural\\:\\ 0\\.03053696501846592\ \(0\)\
\-\ common\\:\\ 0\\.027438861496397512\ \(0\)\
\-\ \\-diuresis\\:\\ 0\\.027041467558179443\ \(0\)\
\-\ \\-placement\\:\\ 0\\.027041467558179443\ \(0\)\
\-\ abscess\\/pneumonia\\:\\ 0\\.027041467558179443\ \(0\)\
\-\ effusions\\:\\ 0\\.026755651090263743\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.026408950413801525\ \(0\)\
\-\ descending\\:\\ 0\\.025589739416105067\ \(0\)\
\-\ mediastinum\\:\\ 0\\.0252456322587367\ \(0\)\
\-\ into\\:\\ 0\\.02494878979091665\ \(0\)\
\-\ most\\:\\ 0\\.024206566156172712\ \(0\)\
\-\ diagnosis\\:\\ 0\\.024076310807121717\ \(0\)\
\-\ age\\:\\ 0\\.023934757597033497\ \(0\)\
\-\ \\-chemotherapy\\:\\ 0\\.023671491212571744\ \(0\)\
\-\ \\-patient\\:\\ 0\\.02278903086762763\ \(0\)\
\-\ encircling\\:\\ 0\\.02278903086762763\ \(0\)\
\-\ mediastinal\\:\\ 0\\.022258482319789833\ \(0\)\
\-\ cxr\\:\\ 0\\.022122897368865507\ \(0\)\
\-\ succumbed\\:\\ 0\\.022104541446418397\ \(0\)\
\-\ robbins\\:\\ 0\\.022104541446418397\ \(0\)\
\-\ adolescence\\:\\ 0\\.021545272867295837\ \(0\)\
\-\ spanning\\:\\ 0\\.020662812522351724\ \(0\)\
\-\ cured\\:\\ 0\\.020301514866964045\ \(0\)\
\-\ malignancy\\:\\ 0\\.02025821888221789\ \(0\)\
\-\ based\\:\\ 0\\.01999196541268074\ \(0\)\
\-\ pelvis\\:\\ 0\\.019049640531236985\ \(0\)\
\-\ stents\\:\\ 0\\.018734565100810698\ \(0\)\
\-\ 20\\.\\:\\ 0\\.01853659417707582\ \(0\)\
\-\ adolescents\\:\\ 0\\.01853659417707582\ \(0\)\
\-\ \\,\\:\\ 0\\.018268777427547\ \(0\)\
\-\ embryonal\\:\\ 0\\.017702441675592255\ \(0\)\
\-\ three\\:\\ 0\\.017672541278201906\ \(0\)\
\-\ large\\:\\ 0\\.017195175753046747\ \(0\)\
\-\ classified\\:\\ 0\\.017167615334657355\ \(0\)\
\-\ 6th\\:\\ 0\\.017167615334657355\ \(0\)\
\-\ disease\\:\\ 0\\.017137883941296984\ \(0\)\
\-\ findings\\:\\ 0\\.01673776321279104\ \(0\)\
\-\ consisting\\:\\ 0\\.01650776447693666\ \(0\)\
\-\ histological\\:\\ 0\\.0163159842407976\ \(0\)\
\-\ compressing\\:\\ 0\\.015883227804417525\ \(0\)\
\-\ her\\:\\ 0\\.015763261708496536\ \(0\)\
\-\ basis\\:\\ 0\\.01572588641059068\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.015668875703346356\ \(0\)\
\-\ alveolar\\:\\ 0\\.01565014220019077\ \(0\)\
\-\ portable\\:\\ 0\\.015576223330316349\ \(0\)\
\-\ abdomen\\:\\ 0\\.015529964803041082\ \(0\)\
\-\ ureteral\\:\\ 0\\.015364588755203003\ \(0\)\
\-\ s\\:\\ 0\\.015035384460825687\ \(0\)\
\-\ symptom\\:\\ 0\\.014862658007406064\ \(0\)\
\-\ 1999\\:\\ 0\\.014862658007406064\ \(0\)\
\-\ pertinent\\:\\ 0\\.014749034474644256\ \(0\)\
\-\ childhood\\:\\ 0\\.014749034474644256\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.014749034474644256\ \(0\)\
\-\ include\\:\\ 0\\.014706463116750225\ \(0\)\
\-\ months\\:\\ 0\\.014318658249632315\ \(0\)\
\-\ information\\:\\ 0\\.014284157486524006\ \(0\)\
\-\ ureter\\:\\ 0\\.01414363743734826\ \(0\)\
\-\ final\\:\\ 0\\.01414363743734826\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.01396576241388093\ \(0\)\
\-\ gestational\\:\\ 0\\.01396576241388093\ \(0\)\
\-\ vena\\:\\ 0\\.01388054902704941\ \(0\)\
\-\ cava\\:\\ 0\\.013797638989049657\ \(0\)\
\-\ occasionally\\:\\ 0\\.013797638989049657\ \(0\)\
\-\ least\\:\\ 0\\.013137788131328964\ \(0\)\
\-\ overall\\:\\ 0\\.013040399486192216\ \(0\)\
\-\ anomaly\\:\\ 0\\.012977150138944559\ \(0\)\
\-\ 65\\:\\ 0\\.012794869708052534\ \(0\)\
\-\ soft\\:\\ 0\\.012766421864991105\ \(0\)\
\-\ granulomatous\\:\\ 0\\.012650829882629923\ \(0\)\
\-\ prognosis\\:\\ 0\\.012433572052664854\ \(0\)\
\-\ tissue\\:\\ 0\\.012425896861672354\ \(0\)\
\-\ \\;\\:\\ 0\\.012425896861672354\ \(0\)\
\-\ dyspnea\\:\\ 0\\.012407465642640593\ \(0\)\
\-\ discussion\\:\\ 0\\.012280165854583068\ \(0\)\
\-\ other\\:\\ 0\\.012083672077929132\ \(0\)\
\-\ origin\\:\\ 0\\.012017419092072353\ \(0\)\
\-\ 13\\:\\ 0\\.011839544068605023\ \(0\)\
\-\ healthy\\:\\ 0\\.011818017772106107\ \(0\)\
\-\ left\\:\\ 0\\.011731352997213678\ \(0\)\
\-\ started\\:\\ 0\\.011691939012334476\ \(0\)\
\-\ sarcoma\\:\\ 0\\.01167142064377375\ \(0\)\
\-\ pathologic\\:\\ 0\\.011473449720038869\ \(0\)\
\-\ causing\\:\\ 0\\.011323786639764537\ \(0\)\
\-\ children\\:\\ 0\\.011323786639764537\ \(0\)\
\-\ continued\\:\\ 0\\.011287484622442443\ \(0\)\
\-\ aorta\\:\\ 0\\.011251607199855967\ \(0\)\
\-\ inflammation\\:\\ 0\\.0111464259928663\ \(0\)\
\-\ before\\:\\ 0\\.011095157646321081\ \(0\)\
\-\ \\(\\:\\ 0\\.011079167580427308\ \(0\)\
\-\ ed\\:\\ 0\\.011078256861624855\ \(0\)\
\-\ shortness\\:\\ 0\\.011028106131558815\ \(0\)\
\-\ best\\:\\ 0\\.011028106131558815\ \(0\)\
\-\ previously\\:\\ 0\\.011011569786053058\ \(0\)\
\-\ ct\\:\\ 0\\.010999726871705917\ \(0\)\
\-\ \\)\\:\\ 0\\.010943829633639648\ \(0\)\
\-\ mass\\:\\ 0\\.0109367577326463\ \(0\)\
\-\ references\\:\\ 0\\.010898246119820898\ \(0\)\
\-\ arising\\:\\ 0\\.010850931793668655\ \(0\)\
\-\ initially\\:\\ 0\\.010668651362776626\ \(0\)\
\-\ treatment\\:\\ 0\\.010611146991416485\ \(0\)\
\-\ 15\\:\\ 0\\.010455051081307913\ \(0\)\
\-\ effusion\\:\\ 0\\.009960656196949084\ \(0\)\
\-\ greater\\:\\ 0\\.00984575569837577\ \(0\)\
\-\ compression\\:\\ 0\\.009812108362883211\ \(0\)\
\-\ breath\\:\\ 0\\.00980097410505935\ \(0\)\
\-\ laboratory\\:\\ 0\\.009659790600779344\ \(0\)\
\-\ diagnosed\\:\\ 0\\.009638635450291429\ \(0\)\
\-\ ap\\:\\ 0\\.00958637720749214\ \(0\)\
\-\ middle\\:\\ 0\\.00958637720749214\ \(0\)\
\-\ congenital\\:\\ 0\\.00958637720749214\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.009395539218223514\ \(0\)\
\-\ kidney\\:\\ 0\\.00923430507684052\ \(0\)\
\-\ benign\\:\\ 0\\.009046166770040494\ \(0\)\
\-\ neoplasm\\:\\ 0\\.008926860662306527\ \(0\)\
\-\ inferior\\:\\ 0\\.008893608470426573\ \(0\)\
\-\ on\\:\\ 0\\.008882098311232246\ \(0\)\
\-\ space\\:\\ 0\\.008670420267106242\ \(0\)\
\-\ radiation\\:\\ 0\\.008601997698043977\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.00852772083264338\ \(0\)\
\-\ often\\:\\ 0\\.008363415793005069\ \(0\)\
\-\ differential\\:\\ 0\\.008321962666726778\ \(0\)\
\-\ image\\:\\ 0\\.008187696829133746\ \(0\)\
\-\ approximately\\:\\ 0\\.008109870633606082\ \(0\)\
\-\ days\\:\\ 0\\.008033970233656373\ \(0\)\
\-\ usually\\:\\ 0\\.007959902619223188\ \(0\)\
\-\ diffuse\\:\\ 0\\.00793560558397336\ \(0\)\
\-\ decreased\\:\\ 0\\.007793731296701103\ \(0\)\
\-\ from\\:\\ 0\\.00776954425247983\ \(0\)\
\-\ and\\:\\ 0\\.0077304480989296275\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0074914068539554774\ \(0\)\
\-\ following\\:\\ 0\\.007439502321782664\ \(0\)\
\-\ weeks\\:\\ 0\\.007439502321782664\ \(0\)\
\-\ likely\\:\\ 0\\.007393527502870112\ \(0\)\
\-\ y\\/o\\:\\ 0\\.007259598250980493\ \(0\)\
\-\ one\\:\\ 0\\.007103470500952896\ \(0\)\
\-\ due\\:\\ 0\\.00699471519310687\ \(0\)\
\-\ than\\:\\ 0\\.006868248021221699\ \(0\)\
\-\ these\\:\\ 0\\.006821609484533252\ \(0\)\
\-\ patients\\:\\ 0\\.006783971163699466\ \(0\)\
\-\ anterior\\:\\ 0\\.006750898232401035\ \(0\)\
\-\ for\\:\\ 0\\.006709584189963636\ \(0\)\
\-\ metastatic\\:\\ 0\\.006598495103116842\ \(0\)\
\-\ in\\:\\ 0\\.0064631477015376524\ \(0\)\
\-\ physical\\:\\ 0\\.006430997759451652\ \(0\)\
\-\ surgery\\:\\ 0\\.006365027804786119\ \(0\)\
\-\ chest\\:\\ 0\\.006272174846802205\ \(0\)\
\-\ \\%\\:\\ 0\\.006114481697380392\ \(0\)\
\-\ posterior\\:\\ 0\\.006041836038964566\ \(0\)\
\-\ can\\:\\ 0\\.0059454673388621765\ \(0\)\
\-\ this\\:\\ 0\\.005896547320945602\ \(0\)\
\-\ it\\:\\ 0\\.005892172958690235\ \(0\)\
\-\ exam\\:\\ 0\\.005758386318863614\ \(0\)\
\-\ case\\:\\ 0\\.005734676174439481\ \(0\)\
\-\ the\\:\\ 0\\.0055130082857274085\ \(0\)\
\-\ female\\:\\ 0\\.005388835188490287\ \(0\)\
\-\ patient\\:\\ 0\\.0052551652203459386\ \(0\)\
\-\ which\\:\\ 0\\.004893081555958739\ \(0\)\
\-\ history\\:\\ 0\\.0036202899929665138\ \(0\)\
\-\ of\\:\\ 0\\.003573736220797191\ \(0\)\
\-\ are\\:\\ 0\\.0035732327378208643\ \(0\)\
\-\ at\\:\\ 0\\.003551420714207463\ \(0\)\
\-\ is\\:\\ 0\\.003449636677206906\ \(0\)\
\-\ or\\:\\ 0\\.0030721556716678147\ \(0\)\
\-\ year\\:\\ 0\\.0029328382493034196\ \(0\)\
\-\ right\\:\\ 0\\.0027657414389890083\ \(0\)\
\-\ no\\:\\ 0\\.002639399235287736\ \(0\)\
\-\ to\\:\\ 0\\.0026200497450489953\ \(0\)\
\-\ with\\:\\ 0\\.0014356340624526347\ \(0\)\
\-\ \\.\\:\\ 0\\.000653365695043183\ \(0\)\
